SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

DIRECTORS’ DEALING

15 Mar 2024 10:35

RNS Number : 0602H
Ebiquity PLC
15 March 2024
Β 

15 March 2024

Β 

Β 

Ebiquity Plc

("the Company" or "Ebiquity")

Β 

DIRECTORS' DEALING

Β 

The Company announces that Nick Waters, Chief Executive Officer, was granted an award over 1,094,288 ordinary shares of 25p each in the Company ("Ordinary Shares") under the Company's share option plan yesterday. Julia Hubbard, Chief Financial Officer was also granted an award yesterday over 481,844 Ordinary Shares under the same plan. These awards are in the form of nil priced options. They were granted in relation to FY 2023 and are subject to a performance target based on earnings per share being met at the end of the three year period to 31 December 2025.

Β 

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail in respect of the transactions described above.Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Nick Waters

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ebiquity plc

b)

LEI:

2138004YRTDJ7FJSWF20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument? (ii) each type of transaction? (iii) each date? and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 25p each

GB0004126057

b)

Nature of the transaction:

Grant of share option award

c)

Price(s) and volume(s):

Price(s)

Volume(s)

nil

1,094,288

d)

Aggregated information:

Β· Aggregated volume:

Β· Price:

Single transaction as in 4 c) above

1,094,288

nil

e)

Date of the transaction:

2024-03-14

f)

Place of the transaction:

Outside of a trading venue

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Julia Hubbard

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ebiquity plc

b)

LEI:

2138004YRTDJ7FJSWF20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument? (ii) each type of transaction? (iii) each date? and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 25p each

GB0004126057

b)

Nature of the transaction:

Grant of share option award

c)

Price(s) and volume(s):

Price(s)

Volume(s)

nil

481,844

d)

Aggregated information:

Β· Aggregated volume:

Β· Price:

Single transaction as in 4 c) above

481,844

nil

e)

Date of the transaction:

2024-03-14

f)

Place of the transaction:

Outside of a trading venue

Β 

Enquiries:

Β 

Ebiquity plc

Nick Waters (CEO)

Julia Hubbard (CFO)

Lorraine Young (Company Secretary)

Β 

+44 (0) 20 7650 9600

Β 

Camarcco

Ben Woodford

Geoffrey Pelham-Lane

+44 (0) 7990 653 341

+44 (0) 7733 124 226

Β 

Panmure Gordon (Financial Adviser, NOMAD & Broker)

Dominic Morley / Dougie McLeod (Corporate Advisory)

Mark Murphy / Sam Elder (Corporate Broking)

Β 

+44 (0) 20 7886 2500

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUVORRSSUOAAR
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.